CL
HRMY icon

CIM LLC’s Harmony Biosciences HRMY Stock Holding History

CIM LLC’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
13,326
+246
+2% +$7.76K 0.06% 137
2026
Q1 		$366K Hold
13,080
– – 0.05% 139
2025
Q4 		$489K Sell
13,080
-561
-4% -$18.4K 0.06% 124
2025
Q3 		$376K Hold
13,641
– – 0.05% 137
2025
Q2 		$431K Buy
13,641
+730
+6% +$23.5K 0.06% 126
2025
Q1 		$429K Sell
12,911
-485
-4% -$17.4K 0.06% 113
2024
Q4 		$461K Buy
13,396
+92
+0.7% +$3.16K 0.07% 123
2024
Q3 		$532K Sell
13,304
-217
-2% -$7.62K 0.08% 113
2024
Q2 		$481K Buy
13,521
+1,705
+14% +$51.3K 0.07% 109
2024
Q1 		$397K Buy
11,816
+117
+1% +$3.75K 0.06% 117
2023
Q4 		$368K Buy
11,699
+3,257
+39% +$90.9K 0.06% 116
2023
Q3 		$277K Buy
8,442
+835
+11% +$29K 0.05% 125
2023
Q2 		$268K Buy
7,607
+418
+6% +$14.4K 0.05% 131
2023
Q1 		$235K Sell
7,189
-183
-2% -$8.33K 0.05% 138
2022
Q4 		$353K Sell
7,372
-277
-4% -$15.2K 0.07% 123
2022
Q3 		$453K Buy
7,649
+533
+7% +$26K 0.1% 107
2022
Q2 		$390K Sell
7,116
-106
-1% -$4.77K 0.08% 105
2022
Q1 		$341K Buy
+7,222
New +$295K 0.06% 116

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM LLC's HRMY Position: Q2 2026 in Review

CIM LLC increased its Harmony Biosciences (HRMY) stake by 1.9% in Q2 2026, buying an estimated $7.76K and bringing the position to 13,326 shares worth $485K. The position accounts for 0.06% of the portfolio, ranked #137.

CIM LLC first reported a position in HRMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $532K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • CIM LLC held 13,326 shares of Harmony Biosciences worth $485K as of Q2 2026.
  • CIM LLC bought 246 Harmony Biosciences shares in Q2 2026, an estimated $7.76K.
  • Harmony Biosciences made up 0.06% of CIM LLC's portfolio in Q2 2026, its #137 holding.
  • CIM LLC first reported a position in Harmony Biosciences in Q1 2022 and has held it in 18 quarters since.
  • CIM LLC's Harmony Biosciences position peaked at $532K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on CIM LLC's 13F filing for Q2 2026, filed 13 Aug 2026.